312 related articles for article (PubMed ID: 15110319)
1. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
[TBL] [Abstract][Full Text] [Related]
2. Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM; Wanders RJ
Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
[TBL] [Abstract][Full Text] [Related]
3. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
4. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
van den Brink DM; van Miert JM; Wanders RJ
J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
[TBL] [Abstract][Full Text] [Related]
5. Assay for Sjögren-Larsson syndrome based on a deficiency of phytol degradation.
van den Brink DM; van Miert JM; Wanders RJ
Clin Chem; 2005 Jan; 51(1):240-2. PubMed ID: 15613721
[No Abstract] [Full Text] [Related]
6. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the final step in the conversion of phytol into phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Wanders RJ
J Biol Chem; 2005 Jul; 280(29):26838-44. PubMed ID: 15866875
[TBL] [Abstract][Full Text] [Related]
8. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
9. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Rizzo WB; Craft DA
J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
[TBL] [Abstract][Full Text] [Related]
10. Disorders related to the metabolism of phytanic acid.
Stokke O; Skjeldal OH; Høie K
Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
[TBL] [Abstract][Full Text] [Related]
12. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
Komen JC; Duran M; Wanders RJ
Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
[TBL] [Abstract][Full Text] [Related]
13. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol.
Friedman KJ; Shapiro SS
Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050
[TBL] [Abstract][Full Text] [Related]
14. Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing.
Ashibe B; Hirai T; Higashi K; Sekimizu K; Motojima K
J Biol Chem; 2007 Jul; 282(28):20763-73. PubMed ID: 17510064
[TBL] [Abstract][Full Text] [Related]
15. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
16. In vitro conversion of phytol to phytanic acid in rat liver: subcellular distribution of activity and chemical characterization of intermediates using a new bromination technique.
Muralidharan FN; Muralidharan VB
Biochim Biophys Acta; 1985 Jun; 835(1):36-40. PubMed ID: 4005274
[TBL] [Abstract][Full Text] [Related]
17. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
18. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Haug S; Braun-Falco M
Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
[TBL] [Abstract][Full Text] [Related]
20. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
